07-12-2010 11:07 "Orexigen Therapeutics (OREX) shares are flat in the regular session after the company told a US Food and Drug Administration panel that its Contrave weight-loss drug can help patients lose weight safely, Reuters reported.
See more here:
Orexigen Therapeutics Shares Flat After Firm Says Diet Drug Safe for Approval - Video
